Jane Street’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
Jane Street's ABVX Position: Q3 2026 in Review
Jane Street increased its Abivax (ABVX) stake by 50% in Q3 2026, buying an estimated $3.63M and bringing the position to 90,331 shares worth $8.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2932.
Jane Street first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. The position peaked at $57.1M in Q4 2025. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Jane Street held 90,331 shares of Abivax worth $8.94M as of Q3 2026.
- Jane Street bought 30,136 Abivax shares in Q3 2026, an estimated $3.63M.
- Abivax made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #2932 holding.
- Jane Street first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
- Jane Street's Abivax position peaked at $57.1M in Q4 2025.
- 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.